Cargando…

Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome

BACKGROUND: As a member of peroxiredoxin (PRX) family, PRX3 is predominantly located in mitochondria and plays an important role of free radical scavenging. Since a body of evidence demonstrated the involvement of PRX3 in insulin secretion, insulin sensitivity, and glucose metabolism, the present st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hou-Li, Li, Tian-Tian, Yu, Ai-Qun, Li, Jingmin, Li, Xiaoyan, Li, Lianqin, Kaifu, Tomonori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419434/ https://www.ncbi.nlm.nih.gov/pubmed/30871530 http://dx.doi.org/10.1186/s12902-019-0358-3

Ejemplares similares

Role of peroxiredoxin III in the pathogenesis of pre-eclampsia as evidenced in mice
por: Li, Lianqin, et al.
Publicado: (2010)

Anti-apoptotic role of peroxiredoxin III in cervical cancer cells()
por: Li, Lianqin, et al.
Publicado: (2012)

Downregulated Expression of Peroxiredoxin 4 in Granulosa Cells from Polycystic Ovary Syndrome
por: Meng, Yan, et al.
Publicado: (2013)

The prognostic values of the peroxiredoxins family in ovarian cancer
por: Li, Saisai, et al.
Publicado: (2018)

Elevated ovarian pentraxin 3 in polycystic ovary syndrome
por: Pan, Jiexue, et al.
Publicado: (2021)

Cardiometabolic aspects of polycystic ovarian syndrome
por: Cho, Li Wei, et al.
Publicado: (2007)

Post-glucose insulin level in polycystic ovarian syndrome
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Evaluation of Homocysteine Levels in Patients with Polycystic Ovarian Syndrome
por: Salehpour, Saghar, et al.
Publicado: (2011)

ANGPTL4 Expression in Ovarian Granulosa Cells Is Associated With Polycystic Ovary Syndrome
por: Jiang, Qi, et al.
Publicado: (2022)

Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment
por: Liu, Yali, et al.
Publicado: (2022)

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
por: Huang, Ying, et al.
Publicado: (2014)

High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
por: Hemati, Tayebe, et al.
Publicado: (2011)

The Source of Polycystic Ovarian Syndrome
por: Raperport, Claudia, et al.
Publicado: (2019)

Polycystic Ovarian Syndrome in Adolescents
por: Adone, Avanti, et al.
Publicado: (2023)

Association between circulating adiponectin levels and polycystic ovarian syndrome
por: Mirza, Saira Saeed, et al.
Publicado: (2014)

Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis
por: Zadehmodarres, Shahrzad, et al.
Publicado: (2015)

Serum CCL 18 Levels in Women with Polycystic Ovarian Syndrome
por: Sam, Justin Easow, et al.
Publicado: (2020)

Peroxiredoxin, Senescence, and Cancer
por: Wu, Mengyao, et al.
Publicado: (2022)

Long non-coding RNA H19 regulates proliferation of ovarian granulosa cells via STAT3 in polycystic ovarian syndrome
por: Li, Li, et al.
Publicado: (2019)

Differential expression of peroxiredoxin 3 in laryngeal squamous cell carcinoma
por: Zhang, Hua, et al.
Publicado: (2016)

Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome
por: Li, Na, et al.
Publicado: (2021)

Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome
por: Li, Yuanqi, et al.
Publicado: (2021)

New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer
por: Liu, Ai Ling, et al.
Publicado: (2016)

Peroxiredoxin 3 Inhibits Cardiac Fibrosis in Mice via NOX4-P38 Signalling
por: Xiong, Xiaoqi, et al.
Publicado: (2023)

Insulin Resistance in Polycystic Ovarian Syndrome
por: Purwar, Ananya, et al.
Publicado: (2022)

Preliminary Findings of Platelet-Rich Plasma-Induced Ameliorative Effect on Polycystic Ovarian Syndrome
por: Seyyed Anvari, Samira, et al.
Publicado: (2019)

Persistent megalocystic ovaries after ovarian hyperstimulation syndrome in a postpartum patient with polycystic ovarian syndrome: a case report
por: Shi, Jinghua, et al.
Publicado: (2018)

Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell
por: Zheng, Ming-Jun, et al.
Publicado: (2018)

Peroxiredoxin 3 Inhibits Acetaminophen-Induced Liver Pyroptosis Through the Regulation of Mitochondrial ROS
por: Wang, Yue, et al.
Publicado: (2021)

Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome
por: Sun, Ningyu, et al.
Publicado: (2023)

Significance of Homocysteine Levels in the Management of Polycystic Ovarian Syndrome: A Literature Review
por: Kondapaneni, Varshitha, et al.
Publicado: (2020)

Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure
por: Chen, Jiying, et al.
Publicado: (2021)

Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: An RCT
por: Eftekhar, Maryam, et al.
Publicado: (2019)

Metabolic syndrome in infertile women with polycystic ovarian syndrome
por: Madani, Tahereh, et al.
Publicado: (2016)

UPLC/Q-TOF-MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome
por: Fan, Xuemei, et al.
Publicado: (2019)

Distinct metabolic signatures in blood plasma of bisphenol A–exposed women with polycystic ovarian syndrome
por: Prabhu, Navya B., et al.
Publicado: (2023)

Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome
por: Li, Fei, et al.
Publicado: (2021)

Update on Management of Polycystic Ovarian Syndrome for Dermatologists
por: Gainder, Shalini, et al.
Publicado: (2019)

The Role of INSR & Diabetes in Polycystic Ovarian Syndrome
por: KHAZAMIPOUR, Afrouz, et al.
Publicado: (2018)

The Impact of Mineral Supplementation on Polycystic Ovarian Syndrome
por: ElObeid, Tahra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ghc801ms23n9mf51vn2uql907b